Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jan 24;61(2):211.
doi: 10.3390/medicina61020211.

Chronic Heart Failure and Coronary Artery Disease: Pharmacological Treatment and Cardiac Rehabilitation

Affiliations
Review

Chronic Heart Failure and Coronary Artery Disease: Pharmacological Treatment and Cardiac Rehabilitation

Maria-Alexandra Ciuca-Pană et al. Medicina (Kaunas). .

Abstract

Coronary artery disease is the leading cause of acute and chronic heart failure. Patients with heart failure and ischemic heart disease need a tailored assessment to define the appropriate treatment, while a specific multidisciplinary management plan should be followed. Indeed, several factors should be assessed before starting treatment, such as heart failure symptoms and/or signs, angina, electrocardiographic features, right and left ventricular systolic and diastolic function, serological abnormalities, cardiac structural and functional integrity, and pulmonary function. New scenarios and developments have emerged recently in this field, increasing our knowledge regarding pathophysiology, exercise, and pharmacology. Effective and appropriate management and treatment reduce the risk of death and hospitalization for heart failure. Herein, we provide an updated, state-of-the-art overview of pharmacological treatment and cardiac rehabilitation in patients with chronic heart failure and coronary artery disease. Furthermore, tailored and contemporary management in clinical practice will be proposed for this specific and fragile patient population.

Keywords: cardiac rehabilitation; chronic heart failure; coronary artery disease; guideline-directed medical therapy; pharmacological treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Diagnostic tests in patients with suspected chronic heart failure. The diagnostic algorithm for a patient with chronic coronary syndrome and suspected chronic heart failure is composed of a twelve-lead electrocardiogram, routine blood test, natriuretic peptide dosage, chest radiography, and transthoracic echocardiography. 12-lead ECG = twelve-lead electrocardiogram; BNP = B-type natriuretic peptide; NT-proBNP = N-terminal pro-B-type natriuretic peptide; X-ray = chest radiography.
Figure 2
Figure 2
Core components of cardiac rehabilitation program in patients with chronic heart failure and coronary artery disease. The cardiac rehabilitation program for patients with chronic heart failure and coronary artery disease has the following components: patient assessment, physical activity counseling, diet and nutritional counseling, patient-centered care and education, exercise training, weight control management, cardiovascular risk factor management, psychosocial management, and medication management.
Figure 3
Figure 3
Management algorithm for patients with chronic heart failure and coronary artery disease: exercise assessment and prescription and cardiac rehabilitation program. AHF—acute heart failure; CPET—cardiopulmonary exercise test; CR—cardiac rehabilitation, ECG—electrocardiogram.

References

    1. Ferrari R., Fox K. Heart rate reduction in coronary artery disease and heart failure. Nat. Rev. Cardiol. 2016;13:493–501. doi: 10.1038/nrcardio.2016.84. - DOI - PubMed
    1. Gould K.L., Lipscomb K. Effects of coronary stenoses on coronary flow reserve and resistance. Am. J. Cardiol. 1974;34:48–55. doi: 10.1016/0002-9149(74)90092-7. - DOI - PubMed
    1. Severino P., D’Amato A., Pucci M., Infusino F., Birtolo L.I., Mariani M.V., Lavalle C., Maestrini V., Mancone M., Fedele F. Ischemic Heart Disease and Heart Failure: Role of Coronary Ion Channels. Int. J. Mol. Sci. 2020;21:3167. doi: 10.3390/ijms21093167. - DOI - PMC - PubMed
    1. Vrints C., Andreotti F., Koskinas K.C., Rossello X., Adamo M., Ainslie J., Banning A.P., Budaj A., Buechel R.R., Chiariello G.A., et al. 2024 ESC Guidelines for the management of chronic coronary syndromes: Developed by the task force for the management of chronic coronary syndromes of the European Society of Cardiology (ESC) Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS) Eur. Heart J. 2024;45:3415–3537. - PubMed
    1. McDonagh T.A., Metra M., Adamo M., Gardner R.S., Baumbach A., Böhm M., Burri H., Butler J., Čelutkienė J., Chioncel O., et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. Heart J. 2021;42:3599–3726. - PubMed

MeSH terms

LinkOut - more resources